|
|
 |
|
|
|
|
89. P. F. Renshaw. Personal communication, 1995. |
|
|
|
|
|
|
|
|
90. R. S. Miyaoka, T. K. Lewellen, and A. N. Bice. Dynamic high resolution imaging of rats: design considerations IEEE. Trans. Nucl. Sci. 38: 670677, 1991. |
|
|
|
|
|
|
|
|
91. P. D. Cutler, S. R. Cherry, E. J. Hoffman, W. M. Digby, and M. E. Phelps. Design features and performance of a PET system for animal research. J. Nucl. Med. 33: 595604, 1993. |
|
|
|
|
|
|
|
|
92. C. J. Marriott, J. E. Cadorette, R. Lecompte, V. Scasnar, J. Rousseau, and J. E. van Lier. High Resolution PET imaging and quantitation of pharmaceutical bio-distribution in a small animal using avalanche photodiode detectors. J. Nucl. Med. 35: 13901396, 1994. |
|
|
|
|
|
|
|
|
93. R. Hichwa. Are animal scanners really necessary for PET? J. Nucl. Med. 35: 13961397, 1994. |
|
|
|
|
|
|
|
|
94. M. V. Green, A. Markowitz, T. E. Tedder, M. P. Andrich, E. S. Owens, and R. D. Neuman. SPECT imaging in small animals. J. Nucl. Med. 33: 852, 1992. |
|
|
|
|
|
|
|
|
95. D. B. Campbell. Drug development and Positron Emission Tomography in Developments in Nuclear Medicine Vol 26: PET for drug development and evaluation. D. Comar, Ed. Kluwer Academic Publishers, Dordrecht, Holland, 1995, p. 124. |
|
|
|
|
|
|
|
|
96. D. R. Elmaleh, H. Kizuka, R. N. Janson, G. S. Jones, L. W. Herman, and H. W. Strauss. Structure-localization relationships of 11C-labeled phentermine derivatives: Effect of aromatic substitution. Appl. Radiat. Isot. 44: 821829, 1993. |
|
|
|
|
|
|
|
|
97. E. Livini, A. J. Fischman, S. Ray, D. R. Elmaleh, N. M. Alpert, S. Weiss, J. A. Correia, D. Webb, E. R. Dahl, W. Robeson, D. Margouleff, R. Liss, H. W. Strauss, and R. H. Rubin. Synthesis of 18F-labelled fluconazole and positron emission tomography studies in rabbits. Nucl. Med. Biol. 19: 191199, 1992. |
|
|
|
|
|
|
|
|
98. E. Livini, W. Satterlee, R. L. Robey, C. A. Alt, E. E. Van Meter, J. W. Babich, W. J. Wheeler, D. D. O'Bannon, J. H. Thrall, and A. J. Fischman. Synthesis of [11C] dapoxetine. HCl, a serotonin re-uptake inhibitor: Biodisposition in rat and preliminary PET imaging in the monkey. Nucl. Med. Biol. 21: 669675, 1994. |
|
|
|
|
|
|
|
|
99. J. S. Fowler, N. D. Volkow, J. Logan, R. R. MacGregor, G. J. Wang, and A. P. Wolfe. Alcohol intoxication does not change [14C] cocaine pharmacokinetics in human brain and heart. Synapse 12: 220227, 1992. |
|
|
|
|
|
|
|
|
100. V. W. Pike, R. G. N. Tanner, F. I. Aigbirhio, C. A. J. Freemantle, S. L. Waters, B. C. Page, C. G. Rhodes, P. Olsson, B. G. Ventresca, and T. Jones. Study of disposition of a novel drug propellant 1,1,1, tetrafluoroethane in humans by labelling with fluorine-18 and whole body counting. In:PET for Drug Development and Evaluation. D. Comar, Ed. Kluwer Academic Publishers, The Netherlands, 1995, p. 341353. |
|
|
|
|
|
|
|
|
101. G. E. Duncan, K. Y. Little, J. A. Kirkman, R. S. Koplas, W. E. Stump, and G. R. Breese. Atoradiographic characterisation of [3H] imipramine and [3H] citalopram binding in rat and human brain: Species differences and relationships to serotonin innervation patterns. Brain Res. 591: 181197, 1992. |
|
|
|
|
|
|
|
|
102. G. E. Duncan, K. Y. Little, R. S. Koplas, J. A. Kirkman, G. R. Breese, and W. E. Stump. b-adrenergic receptor distribution in the human and rat hippocampal formation: marked species differences. Brain Res. 561: 8492, 1991. |
|
|
|
|
|